ad image

Company Info

OncoResponse

Drug Discovery & Development

Overview

Contributions

Contributors

Contributions

1 Contributions1 / 1

Clinical Trials

OncoResponse to Present Phase 1 Results of Clinical Study of OR502, anti-LILRB2 Antibody, as a Late-Breaker Poster

OncoResponse

PR-10-24-NI-73Nov 05, 2024

1 / 1

0 Contributors1 / 0

No authors found

1 / 0